Investors

Investors

Model Medicines discuss AI Drug Discovery at JPM 2020 Healthcare Week

Events

Jan 16, 2020

Illustrated portrait of Patrick ONeill, Head of Partnerships and Investor Relations of Model Medicines

Patrick ONeill

Head of Partnerships & Investor Relations

Model Medicines discuss AI Drug Discovery at JPM 2020 Healthcare Week

Model Medicines discuss AI Drug Discovery at JPM 2020 Healthcare Week

Model Medicines discuss AI Drug Discovery at JPM 2020 Healthcare Week

Exploring the Digital Transformation of Healthcare

Illustrated portrait of Patrick ONeill, Head of Partnerships and Investor Relations of Model Medicines

Patrick ONeill

Head of Partnerships & Investor Relations

Related Content

Events

Jul 23, 2026

Model Medicines to Present New Data on MDL-001 at ASV 2026: Broad-Spectrum Antiviral Activity Across Six Viral Families

Model Medicines BIO 2026 presentation on MDL-001 antiviral and MDL-4102 BRD4 programs advancing toward regulatory filings

Events

Jun 22, 2026

Model Medicines to Present Data on Two First-in-Class Programs Ahead of Catalyst Regulatory Filings at the 2026 BIO International Convention in San Diego

Events

Jul 23, 2026

Model Medicines to Present New Data on MDL-001 at ASV 2026: Broad-Spectrum Antiviral Activity Across Six Viral Families

Model Medicines BIO 2026 presentation on MDL-001 antiviral and MDL-4102 BRD4 programs advancing toward regulatory filings

Events

Jun 22, 2026

Model Medicines to Present Data on Two First-in-Class Programs Ahead of Catalyst Regulatory Filings at the 2026 BIO International Convention in San Diego

Events

Jul 23, 2026

Model Medicines to Present New Data on MDL-001 at ASV 2026: Broad-Spectrum Antiviral Activity Across Six Viral Families

Model Medicines BIO 2026 presentation on MDL-001 antiviral and MDL-4102 BRD4 programs advancing toward regulatory filings

Events

Jun 22, 2026

Model Medicines to Present Data on Two First-in-Class Programs Ahead of Catalyst Regulatory Filings at the 2026 BIO International Convention in San Diego